Dr. Saimabanu S. Mansuri, MD

Dr. Mansuri practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Mansuri's NPI, 1467629493, was assigned on May 8, 2008. Dr. Mansuri holds Michigan license 4301090163.

Dr. Mansuri's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Mansuri's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Mansuri is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Mansuri to 1 more hospital, 2 group practices and clinics, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mansuri practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mansuri's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mansuri is licensed in Michigan.

CMS data shows 599 Medicare services from Dr. Mansuri across 9 procedure codes in 2024, for 178 Medicare patients. Medicare paid $56,946 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 178 Medicare patients who saw Dr. Mansuri in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 36% are also on Medicaid. Their average risk score is 4.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mansuri's median patient age at 66, with 53% women.

In 2024, Dr. Mansuri wrote 704 Medicare Part D claims for 132 patients. 93% of them were for generic drugs. CMS names the drug for 574 of them, across 20 drugs with 11 or more claims each, at $46,856 in total drug cost. In 2023, CMS named 549 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mansuri for performance year 2024, reported as part of a group. Dr. Mansuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Mansuri from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Grifols Shared Services North America, Inc. paid the most, $114.